An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity

Yao, F., Zhou, Z., Kim, J., Hang, Q., Xiao, Z., Ton, B. N., Chang, L., Liu, N., Zeng, L., Wang, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04620-y · Cited by 164

Genome‐wide cooperation of EMT transcription factor ZEB1 with YAP and AP‐1 in breast cancer

Feldker, N., Ferrazzi, F., Schuhwerk, H., Widholz, S. A., Guenther, K., Frisch, I., Jakob, K., Kleemann, J., Riegel, D., Bönisch, U., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103209 · Cited by 171

ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

Xu, Y., Huangyang, P., Wang, Y., Xue, L., Devericks, E. N., Nguyen, H. G., Yu, X., Osés-Prieto, J. A., Burlingame, A. L., Miglani, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.036 · Cited by 165

Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts

Ferrari, N., Ranftl, R., Chicherova, I., Slaven, N. D., Moeendarbary, E., Farrugia, A. J., Lam, M., Semiannikova, M., Westergaard, M. C. W., Tchou, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07987-0 · Cited by 164

Predictive and Prognostic Impact of Ferroptosis-Related Genes ACSL4 and GPX4 on Breast Cancer Treated With Neoadjuvant Chemotherapy

Sha, R., Xu, Y., Yuan, C., Sheng, X., Wu, Z., Peng, J., Wang, Y., Lin, Y., Zhou, L., Xu, S., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103560 · Cited by 171

Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer

Liu, R., Graham, K., Glubrecht, D. D., Germain, D. R., Mackey, J. R., & Godbout, R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.075 · Cited by 163

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer

Malorni, L., Piazza, S., Ciani, Y., Guarducci, C., Bonechi, M., Biagioni, C., Hart, C. D., Verardo, R., Leo, A. D., & Migliaccio, I. (2016) · Oncotarget · doi:10.18632/oncotarget.12010 · Cited by 163

Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability

Celià-Terrassa, T., Bastian, C. D., Liu, D. D., Ell, B. J., Aiello, N. M., Wei, Y., Zamalloa, J., Blanco, M. A., Hang, X., Kunisky, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07538-7 · Cited by 163

Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation

Li, Z., Zhang, H., Huang, Y., Huang, J.-H., Sun, P., Zhou, N., Chen, Y., Mai, J., Wang, Y., Yu, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17395-y · Cited by 164

Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Lee, G. Y., Haverty, P. M., Li, L., Kljavin, N. M., Bourgon, R., Lee, J., Stern, H. M., Modrusan, Z. D., Seshagiri, S., Zhang, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2683 · Cited by 164

Changes of N6-methyladenosine modulators promote breast cancer progression

Wu, L., Wu, D., Ning, J., Liu, W., & Zhang, D. (2019) · BMC Cancer · doi:10.1186/s12885-019-5538-z · Cited by 162

Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression

Bakiri, L., Macho‐Maschler, S., Custic, I., Niemiec, J., Guío-Carrión, A., Hasenfuss, S. C., Eger, A., Müller, M. M., Beug, H., & Wagner, E. F. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.157 · Cited by 158

Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1

Takahashi, R., Miyazaki, H., Takeshita, F., Yamamoto, Y., Minoura, K., Ono, M., Kodaira, M., Tamura, K., Mori, M., & Ochiya, T. (2015) · Nature Communications · doi:10.1038/ncomms8318 · Cited by 161

The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer

Hopkins, T. G., Mura, M., Al-Ashtal, H. A., Lahr, R. M., Latip, N. A., Sweeney, K. G., Lu, H., Weir, J., El-Bahrawy, M. A., Steel, J. H., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1515 · Cited by 159

Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site

Singh, S., Lomelino, C. L., Mboge, M. Y., Frost, S. C., & McKENNA, R. V. (2018) · Molecules · doi:10.3390/molecules23051045 · Cited by 156

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth

Rong, B., Zhang, Q., Wan, J., Xing, S., Dai, R., Li, Y., Cai, J., Xie, J., Song, Y., Chen, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108544 · Cited by 152

Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes

Prabhakaran, S., Rizk, V. T., Ma, Z., Cheng, C.-H., Berglund, A. E., Coppola, D., Khalil, F., Mulé, J. J., & Soliman, H. H. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0864-z · Cited by 150

Regulation of breast cancer metastasis signaling by miRNAs

Petri, B. J., & Klinge, C. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09905-7 · Cited by 158

Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression

Primac, I., Maquoi, E., Blacher, S., Heljäsvaara, R., Deun, J. V., Smeland, H. Y., Canale, A., Louis, T., Stuhr, L. E. B., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 155

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance

Karunarathna, U., Kongsema, M., Zona, S., Gong, C., Cabrera, E., Gomes, A., Man, E. P. S., Khongkow, P., Tsang, J. W.-H., Khoo, U., et al. (2015) · Oncogene · doi:10.1038/onc.2015.208 · Cited by 148

G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling

Prentzell, M. T., Rehbein, U., Sandoval, M. C., Meulemeester, A. D., Baumeister, R., Brohée, L., Berdel, B., Bockwoldt, M., Carroll, B., Chowdhury, S. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.024 · Cited by 148

Creatine Mediated Crosstalk between Adipocytes and Cancer Cells Regulates Obesity-Driven Breast Cancer

Maguire, O. A. B., Ackerman, S. E., Szwed, S. K., Maganti, A. V., Marchildon, F., Huang, X., Kramer, D. J., Rosas-Villegas, A., Gelfer, R., Turner, L. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.018 · Cited by 144

Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women

Çolak, D., Nofal, A., AlBakheet, A., Nirmal, M. S., Jeprel, H. A., Eldali, A., Al‐Tweigeri, T., Tulbah, A. M., Ajarim, D. S., Malik, O. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063204 · Cited by 146

CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance

Gao, T., Han, Y. K., Yu, L., Ao, S., Li, Z., & Ji, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091771 · Cited by 143

Genome-wide Profiling of AP-1–Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer

Zhao, C., Qiao, Y., Jonsson, P., Wang, J., Li, X., Rouhi, P., Sinha, I., Cao, Y., Williams, C., & Dahlman‐Wright, K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3396 · Cited by 141

Epithelial-mesenchymal transition leads to NK cell–mediated metastasis-specific immunosurveillance in lung cancer

Chockley, P. J., Chen, J., Chen, G., Beer, D. G., Standiford, T. J., & Keshamouni, V. G. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97611 · Cited by 140

Estrogen receptor prevents p53-dependent apoptosis in breast cancer

Bailey, S. T., Shin, H., Westerling, T., Liu, X. S., & Brown, M. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018858109 · Cited by 143

PROGgene: gene expression based survival analysis web application for multiple cancers

Goswami, C. P., & Nakshatri, H. (2013) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-3-22 · Cited by 141

Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction

Xiong, G., Chen, J., Zhang, G., Wang, S., Kawasaki, K., Zhu, J., Zhang, Y., Nagata, K., Li, Z., Zhou, B. P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911951117 · Cited by 145

Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition

Cordani, M., Oppici, E., Dando, I., Butturini, E., Pozza, E. D., Nadal‐Serrano, M., Oliver, J., Roca, P., Mariotto, S., Cellini, B., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.04.001 · Cited by 140

Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness

Lu, H., Xie, Y., Tran, T. M. L., Lan, J., Yang, Y., Murugan, N. L., Wang, R., Wang, Y. J., & Semenza, G. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138577 · Cited by 139

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

He, Y., Jiang, X., Duan, L., Xiong, Q., Yuan, Y., Liu, P., Jiang, L., Shen, Q., Zhao, S., Yang, C., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01469-6 · Cited by 142

TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis

Matsuo, Y., Park, J.-H., Miyamoto, T., Yamamoto, S., Hisada, S., Alachkar, H., & Nakamura, Y. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010277 · Cited by 139

Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer

Yang, J., AlTahan, A. M., Jones, D. T., Buffa, F. M., Bridges, E., Interiano, R. B., Qu, C., Vogt, N., Li, J., Baban, D. F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422015112 · Cited by 139

SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis

Greene, K. S., Lukey, M. J., Wang, X., Blank, B. S., Druso, J. E., Lin, M.-C. J., Stalnecker, C. A., Zhang, C., Abril, Y. L. N., Erickson, J. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911954116 · Cited by 138

The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor

McLaughlin, S. K., Olsen, S. N., Dake, B. T., Raedt, T. D., Lim, E., Bronson, R. T., Beroukhim, R., Polyák, K., Brown, M. A., Kuperwasser, C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.004 · Cited by 137

Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness

Nguyen, A., Yoshida, M., Goodarzi, H., & Tavazoie, S. F. (2016) · Nature Communications · doi:10.1038/ncomms11246 · Cited by 136

Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer

McDermott, M. S. J., Chumanevich, A. A., Lim, C., Liang, J., Chen, M., Altilia, S., Oliver, D., Rae, J. M., Shtutman, M. S., Kiaris, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14894 · Cited by 137

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

Voisin, M., de Médina, P., Mallinger, A., Dalenc, F., Huc‐Claustre, E., Leignadier, J., Serhan, N., Soulès, R., Segala, G., Mougel, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707965114 · Cited by 135

Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway

Balanis, N. G., Wendt, M. K., Schiemann, B. J., Wang, Z., Schiemann, W. P., & Carlin, C. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475277 · Cited by 136

TET2 coactivates gene expression through demethylation of enhancers

Wang, L., Ozark, P. A., Smith, E. R., Zhao, Z., Marshall, S. A., Rendleman, E. J., Piunti, A., Ryan, C., Whelan, A. L., Helmin, K. A., et al. (2018) · Science Advances · doi:10.1126/sciadv.aau6986 · Cited by 137

Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer

Feigin, M. E., Akshinthala, S. D., Araki, K., Rosenberg, A. Z., Muthuswamy, L. B., Martin, B., Lehmann, B. D., Berman, H. K., Pietenpol, J. A., Cardiff, R. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3415 · Cited by 135

CCNB1 is a prognostic biomarker for ER+ breast cancer

Ding, K., Li, W., Zou, Z., Zou, X., & Wang, C. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.013 · Cited by 135

A gene regulatory network to control EMT programs in development and disease

Fazilaty, H., Rago, L., Youssef, K. K., Ocaña, O. H., García-Asencio, F., Arcas, A., Galcerán, J., & Nieto, M. A. (2019) · Nature Communications · doi:10.1038/s41467-019-13091-8 · Cited by 138

Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer

Gong, P., Shao, Y.-C., Yang, Y. T., Song, W., He, X., Zeng, Y., Huang, S., Wei, L., & Zhang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578963 · Cited by 133

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

Simigdala, N., Gao, Q., Pancholi, S., Røberg‐Larsen, H., Zvelebil, M., Ribas, R., Folkerd, E. J., Thompson, A., Bhamra, A., Dowsett, M., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0713-5 · Cited by 137

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

Dong, P., Xiong, Y., Yue, J., Hanley, S. J. B., & Watari, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00264 · Cited by 133

BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome

Madden, S. F., Clarke, C., Gaule, P., Aherne, S. T., O’Donovan, N., CLYNES, M. M., Crown, J. P., & Gallagher, W. M. (2013) · Breast Cancer Research · doi:10.1186/bcr3444 · Cited by 135

Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcène, A., Bianchi, E., Gofflot, S., Drion, P. V., Trombino, G. E., Valentin, E. D., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001871 · Cited by 134

Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis

Muliaditan, T., Caron, J., Okesola, M., Opzoomer, J. W., Kosti, P., Georgouli, M., Gordon, P., Lall, S. K., Kuzeva, D. M., Pedro, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05346-7 · Cited by 128

Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer

Niu, J., Xue, A., Chi, Y., Xue, J., Wang, W., Zhao, Z., Fan, M., Yang, C. H., Shao, Z.-M., Pfeffer, L. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.189 · Cited by 132

BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling

Andrieu, G. P., Tran, A. H., Strissel, K. J., & Denis, G. V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0559 · Cited by 136

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer

Formisano, L., Stauffer, K. M., Young, C. D., Bhola, N. E., Zotano, Á. G., Jansen, V. M., Estrada, M. M., Hutchinson, K. E., Giltnane, J. M., Schwarz, L. J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1232 · Cited by 133

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination

Li, C., Du, L., Ren, Y., Liu, X., Jiao, Q., Cui, D., Wen, M., Wang, C., Wei, G., Wang, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1069-3 · Cited by 133

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

Patten, D. K., Corleone, G., Győrffy, B., Perone, Y., Slaven, N., Barozzi, I., Erdős, E., Saiakhova, A., Goddard, K. S., Vingiani, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0091-x · Cited by 134

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Asleh, K., Negri, G. L., Miko, S. E. S., Colborne, S., Hughes, C. S., Wang, X. Q., Gao, D., Gilks, C. B., Chia, S., Nielsen, T. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28524-0 · Cited by 132

Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer

Ni, T., Li, X.-Y., Lu, N., An, T., Liu, Z., Fu, R., Lv, W.-C., Zhang, Y.-W., Xu, X.-J., Rowe, R. G., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3425 · Cited by 129

JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion

Sundqvist, A., Morikawa, M., Ren, J., Vasilaki, E., Kawasaki, N., Kobayashi, M., Koinuma, D., Aburatani, H., Miyazono, K., Heldin, C., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1190 · Cited by 128

Identification of Staphylococcal Nuclease Domain-containing 1 (SND1) as a Metadherin-interacting Protein with Metastasis-promoting Functions

Blanco, M. A., Alečković, M., Hua, Y., Li, T., Wei, Y., Xu, Z., Cristea, I. M., & Kang, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240077 · Cited by 128

ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Vendrell, J. A., Thollet, A., Nguyen, N. T., Ghayad, S. E., Vinot, S., Bièche, I., Grisard, E., Josserand, V., Coll, J., Roux, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3095 · Cited by 131

ANTXR1, a Stem Cell-Enriched Functional Biomarker, Connects Collagen Signaling to Cancer Stem-like Cells and Metastasis in Breast Cancer

Chen, D., Bhat‐Nakshatri, P., Goswami, C. P., Badve, S., & Nakshatri, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1080 · Cited by 130

Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities

Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127

The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis

Ooms, L. M., Binge, L. C., Davies, E. M., Rahman, P., Conway, J. R. W., Gurung, R., Ferguson, D. T., Papa, A., Fedele, C. G., Vieusseux, J. L., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.003 · Cited by 127

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

Khongkow, P., Karunarathna, U., Khongkow, M., Gong, C., Gomes, A., Yagüe, E., Monteiro, L. J., Kongsema, M., Zona, S., Man, E. P. S., et al. (2013) · Oncogene · doi:10.1038/onc.2013.457 · Cited by 131

The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor

Swierczak, A., Cook, A. D., Lenzo, J. C., Restall, C. M., Doherty, J. P., Anderson, R. L., & Hamilton, J. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0190 · Cited by 127

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer

Cheng, G., Fan, X., Hao, M., Wang, J., Zhou, X., & Sun, X. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0515-5 · Cited by 128

The E2F Transcription Factors Regulate Tumor Development and Metastasis in a Mouse Model of Metastatic Breast Cancer

Hollern, D. P., Honeysett, J., Cardiff, R. D., & Andrechek, E. R. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00737-14 · Cited by 124

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)

Fiorillo, M., Lamb, R., Tanowitz, H. B., Cappello, A. R., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2016) · Aging · doi:10.18632/aging.100983 · Cited by 127

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts

Wu, Y., Yi, Z., Li, J., Wei, Y., Feng, R., Liu, J., Huang, J., Chen, Y., Wang, X., Sun, J., et al. (2022) · Theranostics · doi:10.7150/thno.68972 · Cited by 131

Elevated expression of the centromere protein‐A(CENP‐A)‐encoding gene as a prognostic and predictive biomarker in human cancers

Sun, X., Clermont, P., Jiao, W., Helgason, C. D., Gout, P. W., Wang, Y. Z., & Qu, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30133 · Cited by 125

An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer

Yang, F., Shen, Y., Zhang, W., Jin, J., Huang, D., Fang, H., Ji, W., Shi, Y., Tang, L., Chen, W., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0123-6 · Cited by 125

The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity

Lü, D., Liu, L., Sun, Y., Song, J., Yin, Q., Zhang, G., Fang, Q., Hu, Z., Yang, Z., Zhou, Z. C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0577-9 · Cited by 117

Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer

Ding, J., Jin, W., Chen, C., Shao, Z., & Wu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041942 · Cited by 124

Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4

Kolb, R. H., Kluz, P., Tan, Z. W., Borcherding, N. C., Bormann, N. L., Vishwakarma, A., Balcziak, L. K., Zhu, P., Davies, B. S. J., Gourronc, F. A., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0592-6 · Cited by 125

Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation

van Weverwijk, A., Koundouros, N., Iravani, M., Ashenden, M., Gao, Q., Poulogiannis, G., Jungwirth, U., & Isacke, C. M. (2019) · Nature Communications · doi:10.1038/s41467-019-10592-4 · Cited by 126

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22

Patel, J. B., Appaiah, H. N., Burnett, R. M., Bhat‐Nakshatri, P., Wang, G., Mehta, R. J., Badve, S., Thomson, M. J., Hammond, S. M., Steeg, P. S., et al. (2010) · Oncogene · doi:10.1038/onc.2010.510 · Cited by 123

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion

İmani, S., Wei, C., Cheng, J., Khan, M. A., Fu, S., Yang, L., Tania, M., Zhang, X., Xiao, X., Zhang, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15214 · Cited by 123

Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation

Mele, L. L., Noce, M. L., Paino, F., Regad, T., Wagner, S., Liccardo, D., Papaccio, G., Lombardi, A., Caraglia, M., Tirino, V., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1164-5 · Cited by 122

Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer

Pérez-Gómez, E., Andradas, C., Blasco-Benito, S., Caffarel, M. M., García-Taboada, E., Villa‐Morales, M., Moreno, E., Hamann, S., Martín-Villar, E., Flores, J. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv077 · Cited by 124

ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells

Vidovic, D., Huynh, T. T., Konda, P., Dean, C. A., Cruickshank, B. M., Sultan, M., Coyle, K. M., Gujar, S. A., & Marcato, P. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0362-1 · Cited by 121

The Interaction Between lncRNA SNHG6 and hnRNPA1 Contributes to the Growth of Colorectal Cancer by Enhancing Aerobic Glycolysis Through the Regulation of Alternative Splicing of PKM

Lan, Z., Yao, X., Sun, K., Li, A., Liu, S., & Wang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00363 · Cited by 121

Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways

Strong, A. L., Strong, T. A., Rhodes, L. V., Semon, J. A., Zhang, X., Shi, Z., Zhang, S., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3569 · Cited by 124

Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs

Hongu, T., Pein, M., Insua-Rodríguez, J., Gutjahr, E., Mattavelli, G., Meier, J., Decker, K., Descot, A., Bozza, M., Harbottle, R., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00353-6 · Cited by 118

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

Bamodu, O. A., Huang, W.-C., Lee, W., Wu, A. T. H., Wang, L. S., Hsiao, M., Yeh, C., & Chao, T.-Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2108-5 · Cited by 118

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells

Lisek, K., Campaner, E., Ciani, Y., Walerych, D., & Sal, G. D. (2018) · Oncotarget · doi:10.18632/oncotarget.24974 · Cited by 119

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis

Chang, R., Song, L., Xu, Y., Wu, Y., Dai, C., Wang, X., Sun, X., Hou, Y., Li, W., Zhan, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05852-8 · Cited by 118

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors

Sofi, S., Mehraj, U., Qayoom, H., Aisha, S., Almilaibary, A., Alkhanani, M., & Mir, M. A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01748-2 · Cited by 118

CpG island shore methylation regulates caveolin-1 expression in breast cancer

Rao, X., Evans, J. M., Chae, H., Pilrose, J. M., Kim, S., Yan, P. S., Huang, R.-L., Lai, H.-C., Lin, H.-J. L., Liu, Y., et al. (2012) · Oncogene · doi:10.1038/onc.2012.474 · Cited by 120

MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells

Breunig, C., Pahl, J. H. W., Kueblbeck, M., Miller, M., Antonelli, D., Erdem, N., Wirth, C., Will, R. D., Bott, A., Cerwenka, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.364 · Cited by 121

FUNMarker: Fusion Network-Based Method to Identify Prognostic and Heterogeneous Breast Cancer Biomarkers

Li, X., Xiang, J., Wang, J., Li, J., Wu, F., & Li, M. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2973148 · Cited by 123

The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling

Okada, T., Sinha, S., Esposito, I., Schiavon, G., López-Lago, M. A., Su, W., Pratilas, C. A., Abele, C., Hernandez, J. M., Ohara, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3082 · Cited by 117

PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P2‐dependent actin remodeling

Sengelaub, C. A., Navrazhina, K., Ross, J., Halberg, N., & Tavazoie, S. F. (2015) · The EMBO Journal · doi:10.15252/embj.201591973 · Cited by 119

Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis

Cao, J. P., Liu, Z. Z., Cheung, W. K. C., Zhao, M., Chen, S. Y., Chan, S. W., Booth, C. J., Nguyen, D. X., & Yan, Q. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.004 · Cited by 116

EPOP Interacts with Elongin BC and USP7 to Modulate the Chromatin Landscape

Liefke, R., Karwacki-Neisius, V., & Shi, Y. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.019 · Cited by 123

A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity

Hu, J., Li, G., Zhang, P., Zhuang, X., & Hu, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.72 · Cited by 115

Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells

Cappello, P., Blaser, H., Gorrini, C., Lin, D., Elia, A., Wakeham, A. C., Haider, S. A., Boutros, P. C., Mason, J. M., Miller, N. A., et al. (2013) · Oncogene · doi:10.1038/onc.2013.183 · Cited by 114

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

Zhou, C., Zhong, Q., Rhodes, L. V., Townley, I. K., Bratton, M. R., Zhang, Q., Martin, E. C., Elliott, S. G., Collins‐Burow, B. M., Burow, M. E., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3144 · Cited by 114

Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy

Uribesalgo, I., Hoffmann, D., Zhang, Y., Kavirayani, A. M., Lazović, J., Berta, J., Novatchkova, M., Pai, T., Wimmer, R., László, V., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809266 · Cited by 116

Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer

Kao, T., Wu, C.-C., Phan, N. N., Liu, Y.-H., Ta, H. D. K., Anuraga, G., Wu, Y.-F., Lee, K., Chuang, J., & Wang, C. (2021) · Aging · doi:10.18632/aging.203345 · Cited by 114

miR‐206 inhibits cell migration through direct targeting of the actin‐binding protein Coronin 1C in triple‐negative breast cancer

Wang, J., Tsouko, E., Jonsson, P., Bergh, J. C. S., Hartman, J., Aydoğdu, E., & Williams, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.006 · Cited by 112

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410